PROPEL

3 Key Differences Between PROPEL and CTMS

March 13, 2023 by

High staff turnover and burnout have been trending topics in the clinical trials industry over the last year. The goal of successful clinical trials is to get new treatments to market as quickly and safely as possible; however, the process from study startup to study completion is lengthy, and staff turnover causes disruption. With the right technology, standard pre-enrollment steps can be streamlined, automated, and accelerated across your site or site network—ensuring business intelligence is neither overlooked nor forgotten as staffing situations change. 

Furthermore, speeding up the pre-enrollment process can help increase diversity in clinical trials by onboarding sites faster, making your organization look more attractive to sponsors and CROs. 

PROPEL vs. CTMS 

A traditional clinical trial management system (CTMS) is designed to manage patient recruitment, scheduling, and study finances. But if you’re only using a CTMS, it can be hard to proficiently track enrollment and site activity, trial opportunities, timing, and performance across your entire clinical trial operations.   

Fig.1 Unique within the clinical trials industry, PROPEL is an all-inclusive pipeline, startup, trial intelligence, and automation system.

Built for clinical trials, the Devana Solutions tech suite—which includes PROPEL for site networks and LYNK UP for single or emerging sites—is uniquely different from a CTMS. On average, site networks save almost 30 hours of time per week and increase revenue by 40% throughout the end-to-end clinical trial process with PROPEL’s improved workflows, study startup automation, and seamless integrations with popular CTMS and other mission-critical systems for end-to-end operational excellence. With PROPEL, information silos are replaced with organization-wide visibility into trial data and operations. While your CTMS is triggered at recruitment or post-enrollment, PROPEL is involved from initial pipeline management all the way through to study completion and analysis.  

1. Study Startup Automation  

PROPEL and LYNK UP are comprehensive solutions that optimize study startup and performance. Unlike a CTMS, Devana’s category-defining technology allows you to automate your pipeline of trials and your study startup. This allows users to seamlessly track and update milestones throughout the entire startup process. PROPEL transforms the pre-enrollment and study startup process in addition to providing wrap-around reporting every step of the way.   

2. Advanced Custom Analytics & Reporting (from initial pipeline management to study completion) 

Although CTMS includes metrics such as study enrollment, visit tracking, and protocol deviation logs, they do not include other essential insights that give you a comprehensive view of your organization. With PROPEL and LYNK UP, users can leverage additional key metrics such as turnaround timing, study opportunities, and overall study performance reports—enabling you to quickly identify and address bottlenecks to boost startup efficiency and trial performance. PROPEL includes custom dashboards and reports to easily see and share real-time performance metrics by sponsor, CRO, site, indication, and more.  

3. 360-degree View of Your Clinical Trial Operations 

As opposed to a stand-alone CTMS, PROPEL and LYNK UP enable sites to store everything related to ongoing and historical trials all in one place. Now, you can attach documents, emails, call logs, and more to individual study records—saving time and eliminating needless email chains, calls, and meetings. Custom tasks, alerts, and real-time threaded chat conversations facilitate cross-functional communication for both central and remote teams. With PROPEL and LYNK UP, teams can improve workflows, freeing staff from repetitive tasks and multiple clunky systems so they can focus on winning new opportunities. 

Click here to see a full breakdown of how PROPEL compares to a CTMS. 

Seamless Integrations with Industry-Leading CTMS 

PROPEL works in conjunction with your preferred CTMS to provide reporting and analytics across the entire clinical trial process. Data points entered into either system are automatically synchronized across both platforms—cutting out duplicate data entry, boosting efficiency, and decreasing clinical trial cycle times. And because your data is securely stored in one place, drilling down into study and site-specific data and performance insights is simple. 

But PROPEL’s integrations don’t stop at your CTMS. From contact management to email marketing, our open API gives you the power to integrate the tools your team is already using to be successful. Now you can truly have access to all the data and information you need—all in one place.  

From start to finish, PROPEL speeds up the entire clinical trial process, ultimately allowing your organization to respond to more trials and win more of the right awards.  

Already have a CTMS or looking to get one? PROPEL integrates with top CTMS solutions, including RealTime, CRIO, and Advarra’s Clinical Conductor.  

Devana Solutions 

Devana Solutions is an innovative cloud-based clinical trial software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. 

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics clinical trial software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs. 

PROPEL

Boost Study Contract Wins in the Clinical Trial Industry

April 11, 2022 by

Is your clinical trial organization looking to boost study contract wins and shorten the sales cycle? Then you need to ensure you have the right tools in your tech stack. In the age of technology, there are many options available but one you must include is a trial startup software that synchronizes your communication and data for increased efficiency.

A quality trial startup technology solutions provider, like Devana Solutions, will understand the unique challenges of the industry and offer comprehensive solutions such as automated data evaluation and communication that frees the sales team from repetitive tasks so they can focus on winning the study contract.

Devana Solutions Saves Time and Shortens Sales Cycles

By eliminating repetitive tasks, Devana Solutions’ PROPEL platform is able to shorten the overall sales cycle. Put an end to the tedious work in spreadsheets or disparate systems, as PROPEL is able to automate sales processes, capture a complex chain of emails, and account for customized variations.

In addition, PROPEL allows for each cross-functional team to seamlessly communicate with one another and understand what stage the trial is in during the startup process. The best software will be easily accessible to every decision-maker across the trial management process.

How Trial Software Software Boosts Sales in the Clinical Trial Industry

Increased data means more informed decision-making. With a vibrant and dynamic site and investigator database, as well as up to date performance metrics, the sales team is able to focus their efforts to determine the best trial opportunities for their organization. Increased data streams allow the organization to predict how their business development strategies will affect their overall operations.

Choosing the Best Trial Startup Software for Your Clinical Trial Business

The best clinical trial software will be one that is designed with the unique challenges of the clinical trials industry in mind. Offering holistic trial analysis and a dynamic site and investigator database, Devana Solutions’ PROPEL enterprise software gives businesses the crucial support they need to focus their business efforts for much success.

Sign up for a free demo and learn what makes PROPEL the best in the industry.

Devana Solutions

Devana Solutions is an innovative cloud software company that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes. Book a demo with Devana Solutions today to learn about our cloud-based data analytics software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

Events

2022 World Vaccine Congress: What to Expect

March 29, 2022 by

Devana Solutions executives are attending the 2022 World Vaccine Congress in Washington D.C., on April 18-21, 2022. Here’s what leaders in the biopharma industry can expect.The World Vaccine Congress, in existence for over two decades, has grown to become the largest and most established conference dedicated to vaccines, globally. The World Vaccine Congress 2022 will bring together thousands of industry experts across the entire vaccine landscape, with key sessions dedicated to the fight against COVID-19. Taking place April 18-21 at the flagship hotel, Marriott Marquis Washington, DC, the event will be one of the first opportunities to meet in person since the pandemic began to learn, share experiences and ground-breaking knowledge, and network with others who are working against COVID-19 and on other important vaccines.

“If there is anything that the last two years have taught this industry, it’s that the pandemic has certainly put the focus on the need for cutting-edge research to produce more and better vaccines,” Devana Solutions CEO and Co-Founder Barry Lake.

Inside Peek: 2022 World Vaccine Congress Washington

An event that prides itself on covering every subject across the entire vaccine value chain, here is what to expect if you are attending:

  • Visionary Presenters
  • Engaging Agenda
  • Networking Breaks
  • Vaccine Excellence Awards

Visionary Presenters

This year’s presenters are disruptors and visionary industry leaders from the biopharma industry. They are selected for their relevance, dynamism, and insight. Just a handful of speakers at the World Vaccine Congress include:

Engaging Agenda

From basic research to commercial manufacture, World Vaccine Congress covers the whole vaccine value chain where science, government and manufacturers all come together to create ground-breaking progress. If you are involved in vaccines or new to it because of the pandemic, World Vaccine Congress is the most important meeting you will be part of in 2022.

Here are some of the topics discussed each day:

April 18

  • Biodefense and preparedness
  • Maternal immunization
  • Vaccine Technology
  • Antimicrobial resistance
  • Antibodies in treating COVID and infectious diseases
  • HIV

April 19

  • Plenary Sessions
  • Interactive roundtable discussions
  • Evening drinks & ViE Awards Dinner

April 20 & 21

  • COVID, influenza and other respiratory diseases
  • Immune profiling
  • Cancer immunotherapy
  • One health and veterinary vaccines
  • Clinical trials and development
  • Manufacture
  • Safety
  • Market access
  • Supply & logistics
  • Newly infectious and chronic diseases

Networking

Being the first in-person World Vaccine Congress since 2020, networking is an essential part of the conference experience. You can find new opportunities to collaborate or meet other people in your field. With over 30 scheduled networking events, from coffee breaks to luncheons, there is ample opportunity to learn and network with colleagues across the industry.

Vaccine Excellence Awards

On Tuesday, April 19th, the World Vaccine Congress will be hosting the 15th Annual Vaccine Industry Excellence Awards Ceremony & Dinner. The Scientific Advisory Board members will help make the final decision in each category, and the winners will be announced at the dinner.

“Devana Solutions is proud to have supported many of the leading vaccine research site organizations that stepped up in a big way during the COVID pandemic, including hyperCORE International, Benchmark Research, Centricity Research, Javara Research, Velocity Clinical Research and Accel Research Sites. We wanted to be in Washington, D.C. to support many of these clients nominated for well-deserved Vaccine Excellence Awards,” said Lake.

Are you planning on attending the 2022 World Vaccine Congress Washington? We’d love to chat. Devana Solutions’ CEO and Co-founder Barry Lake and Director, Strategic Partnerships, Emily Hardy, will be attending the show in the nation’s capital and are available to discuss how technology can improve your clinical trial management process. Connect with Barry or Emily on LinkedIn or use the contact form at the bottom of the page to set something up before the big event!

About Us

Devana Solutions Enhances Advisory Board with Addition of Velocity Clinical Research’s Craig Koch

March 17, 2022 by

[Chapel Hill, NC, March 17, 2022] Devana Solutions, the leading cloud SaaS provider to the clinical trials industry to connect centralized research professionals to staff and clinicians at decentralized site locations, announced today that industry veteran Craig Koch has joined Devana’s Advisory Board. Koch is currently Executive Vice President of Velocity Clinical Research, a leading integrated research organization in the U.S. with global expansion now underway. Koch will join current Syneos Health Senior Vice President Tom Wollman and longtime software investor and advisor Reid Conrad currently on Devana’s Advisory Board.

“I am delighted to have Craig join our Advisory Board,” stated Barry Lake, Devana Solutions’ CEO, “Velocity Clinical Research is perhaps the most optimized organization now leveraging our advanced PROPEL enterprise platform, and Craig’s analytical skills and leadership are a big reason why. I look forward to his contributions as an advisor to Devana Solutions, particularly with the transformative development initiatives Devana will be delivering to the industry in 2023.”

“Devana Solutions’ began as a tool for clinical research sites where it will remain the gold standard for research site productivity. The flexibility of the platform and the talent of the team also position Devana to be a Solution poised to unify what is a very disjointed industry.”

Founded in 2017, Velocity has grown dramatically in the last few years and now comprises 30 research sites across the United States with current global expansion underway. The Velocity model represents a new approach to site management. By owning and operating all sites directly, the organization offers a robust infrastructure that completely integrates the sites with singular systems and processes. Their model has proven to provide consistent and predictable patient recruitment and engagement. From a systems perspective, Velocity is an extremely technology-enabled organization, and under Koch’s direction, the Devana Solutions platform lies at the heart of Velocity’s business development, feasibility, and pre-award workflows, and both trial enrollment and overall business performance analytics.

According to Lake, “Craig’s expertise in leveraging our technology and industry insights will be a strong addition to Devana’s Advisory Board and our company. I look forward to his contributions.”

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions’ innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials. https://devanasolutions.com/

About Velocity Clinical Research

Velocity Clinical Research, headquartered in Durham, NC, is the leading integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies. Velocity supports global drug development in primarily conducting phase II and phase III clinical trials. The company has 30 U.S. locations across 14 states. Velocity places the care of the patient at the heart of everything we do. With over 35 years of experience running sites and more than 7,000 studies completed, Velocity has refined its patient recruitment strategies while maintaining a focus on delivering timely and reliable data quality. For more information. visit our website at https://velocityclinical.com.

About Us | IGNITE | Partner Spotlight | PROPEL

Devana Solutions Connects Research Operations and Business Intelligence at Scale with Clinical Conductor Integration

March 10, 2022 by

A new interface between Devana’s IGNITE and PROPEL products and Advarra’s Cloud-Based Clinical Trial Management System establishes an end-to-end solution for efficient research conduct and world-class business intelligence.

CHAPEL HILL, NC (March 10, 2022) – Devana Solutions is pleased to announce a new, at scale CTMS- integration solution for research organizations utilizing Advarra’s Clinical Conductor Clinical Trial Management System (CTMS), improving efficiency, and providing research sites with actionable insights across their entire research portfolio.

The Devana <-> Advarra integration is a dynamic, bi-directional data and process flow between Devana’s IGNITE and PROPEL products, and Advarra’s industry-leading Clinical Conductor CTMS. Following the natural progression of a trial, the trial startup begins in Devana, flows through Clinical Conductor for clinical execution and research operations management, and then back to Devana for end-to-end business intelligence. Enrollment performance metrics are derived automatically and pulled into the Devana system as research teams are interacting with Clinical Conductor, reducing duplicative workflows within the systems.

The robust and sought-after analytics, available within the Devana systems, offer configurable views to analyze performance data, by trial or indication, by site, or organization-wide. Combined with Clinical Conductor’s ability to optimize operational finances, regulatory compliance, and overall operational workflows, these integrated products provide a seamless, comprehensive, clinical research solution. After a very thorough and thoughtful technical approach, the Devana <-> Advarra CTMS integration is now live for all Clinical Conductor customers.

“At Devana Solutions, we have always prided ourselves in listening to our clients and being attentive to their needs,” explained Barry Lake, Devana Solutions’ CEO. “So, when the leadership at highly-valued client-partners, Javara Research and Velocity Clinical Research, encouraged an API-integration with Advarra’s Clinical Conductor CTMS to better support their study teams, we were eager to explore it.”

“We were pleased to work closely with the team at Advarra and the integration of both systems has increased our clients’ operational efficiency. We look forward to deploying the connection for the benefit of additional mutual clients. Working together, as an industry, we can and will move mountains!” added Lake.

“We are thrilled to collaborate with Devana and our customers on this innovative interface,” said James Wurdeman, Chief Product Officer at Advarra. “Devana’s approach to developing this integration aligns with our philosophy of creating site-centric, open, customer-focused technology solutions that can be integrated with enterprise systems across a research site or site network.”

Devana Solutions now boasts integrations with several leading CTMS technologies on the market. These integrations speak to more than just added convenience and increased efficiencies; they’re speeding up the clinical trial process resulting in improved clinical outcomes and therapies to patients.

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials. https://devanasolutions.com/

About Advarra

Advarra makes clinical research safer, smarter, and faster. Our integrated solutions help safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance for over 3,500 sponsors, CROs, institutions, academic medical centers, and research consortia.

With trusted and unequaled independent oversight committee services, innovative software solutions for sites, sponsors, and CROs, and experienced consultants with deep-seated connections across the industry, Advarra has the expertise and technology needed to advance clinical research and help our clients make the world a healthier place.

Headquartered in Columbia, Maryland, Advarra’s extensive geographic reach helps clients navigate the evolving research and regulatory environment. https://www.advarra.com/

Partner Spotlight | PROPEL

Accel Research Sites makes clinical trials more accessible with Devana Solutions’ PROPEL platform

March 7, 2022 by

Chapel Hill (February 22, 2022) – Accel Research Sites is bringing clinical trials to even more patients, right where they live and work, thanks to an industry-leading clinical trial platform from Devana Solutions.

Accel is the latest clinical trial network to convert to Devana’s PROPEL Enterprise Platform, which will help the organization connect central teams to site-based staff and clinicians. The company previously used Devana’s IGNITE platform to automate workflow at the start of studies and to gain insight into performance metrics.

“PROPEL literally brings the site to the patient,” according to Barry Lake, Devana Solutions’ CEO and Co-Founder. “Like most leading research site networks, our Accel client-partner has used our IGNITE technology to standardize the trial startup workflows and analytics for their central operations team but, with PROPEL, Accel’s clin-ops professionals collaborate in a common cloud with their site-based colleagues, providing patients with access to trials in the communities where they live and work. We are thrilled that the team at Accel is leading this transformational shift.”

Accel will use PROPEL to connect the centralized management team in Florida with clinicians across 24 sites. With the shift from IGNITE, Accel will see increased efficiencies and precision around site selection, as well as faster site startup and exceptional trial execution.

“When the pandemic hit, we at Accel had to reimagine many of our normal processes so we could both help with the global health crisis and continue to keep our participants healthy and safe,” said Lora Parahovnik, CEO. “Working with Devana has helped us become more efficient. We’re looking forward to continuing to push forward in clinical trial operations by leaning on a cutting-edge platform like PROPEL.”

Devana Solutions is a market leader in clinical trial SaaS for study startup automation, metrics capture and analytics. Accel has been a partner since 2019, recently moving to the PROPEL platform as the company has grown.

For more information about Devana Solutions, visit https://devanasolutions.com/. For more information about Accel Research Sites, visit https://accelresearchsites.com/.

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials.

About Accel Research Sites

Accel Research Sites is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. They partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies worldwide to advance healthcare and wellness in the communities they serve.

Events

SCOPE 2022 Recap: Takeaways from Clinical Ops Executives

February 22, 2022 by

The 2022 Summit for Clinical Operations Executives (SCOPE) has come to a close. Clinical operations executives from all parts of North America gathered in Orlando, Florida, to share the latest innovations in clinical trial recruitment, management, and analysis. Devana Solutions CEO and Co-Founder Barry Lake and Vice President of Operations Linda Parks attended the event to keep up with the latest trends and share how Devana Solutions’ cutting-edge platforms help pharmaceutical sponsors and clinical research organizations keep up with the rapid pace of technology adoption.

Our CTMS partners exhibiting were kind enough to refer Devana Solutions as a complementary platform to those stopping by their booths with a need for business development or startup solutions. Special shout-out to Elise Tawfiq of RealTime CTMS, as well as Mia Castagnero and Eric Elander of Clinical Research IO (CRIO) and the entire CRIO team for their hospitality.

We started the week by making history teeing off at SCOPE’s Inaugural Masters of Clinical Research Golf Tournament.

 

 

In between speakers and breakout sessions, the week was filled with talks from industry thought leaders and networking opportunities with colleagues. Since the first day, we were fortunate to spend time discussing the challenges of and solutions to patient recruitment in multisite studies with Trialbee CEO Matt Walz.

We congratulated Rick Riegel, for becoming the most recent member to join the Board of Directors at RealTime CTMS. We know that he will be a great asset to our friends at RealTime CTMS.

Although the clinical research industry is driven by technology, it’s the face-to-face interactions at conferences like these that put our work into perspective: “people caring for people.”

SCOPE 2022 Recap: Takeaways from Clinical Ops Executives with Devana Solutions
From left to right: Centricity CEO and Co-Founder of hyperCORE Jeff Kingsley and Devana Solutions Vice President of Operations Linda Parks at the hyperCORE Kick-Off Luau

 

We met with Jill Johnson, President of WCG’s Clinical Services Organization, to celebrate her study planning and site optimization efforts! Using Devana Solutions PROPEL Enterprise Platform’s ability to provide reliable real-time and historic metrics, WCG can ascertain predictable study performance data by directly connecting their research sites and effortlessly manage study feasibility, track study workflow and milestone completion, and oversee site facilities and equipment.

Lastly, we always enjoy spending time discussing how our companies are innovating and leading the clinical trial space with Florence Healthcare CEO Ryan Jones.

“Year after year, we’re seeing the use of technology in drug development continuing at a breakneck pace. The way we conduct research has changed drastically because of it, and there’s no doubt that this trend will continue,” said Lake.

 

 

Vice President of Operations Linda Parks agrees. Thanks to innovations in data technologies, the world of clinical data management and analytics has seen some impressive advancements in recent years. If you’re looking to stay ahead of the curve with the digitization of healthcare data and its cloud storage, then you need to be able to seamlessly share and analyze performance levels across your entire research network.

“More than sites needing a platform that can keep up with the latest trends, they need a platform that can display actionable data in real-time,” said Parks.

It’s clear that Devana Solutions is the category leader when it comes to innovation in the field of pipeline administration, study startup workflow automation, metric analysis, and data visualization. Thanks to Devana Solutions, clinical trials are becoming more efficient every day.

Clinical Trials | PROPEL

Devana Brings Cloud-Based Collaboration to Clinical Trial Central Research Teams

February 14, 2022 by

Bringing Cloud-Based Collaboration to Clinical Trial Central Research TeamsThe pandemic has had a significant impact on the clinical research industry. In response to the COVID-19 pandemic, regulatory authorities have been calling for an increased adoption of decentralized clinical trials (DCTs). Devana Solutions has been pivotal during this time, helping central research operations teams collaborate safely and remotely on our platform and connect to decentralized site staff serving patients in underserved communities.

As a result, our PROPEL cloud solution has taken off as the superior research site-operations and analytics platform for leading research organizations, conducting decentralized trials, around the globe.

The Benefits of Decentralized Trials

More research organizations are moving to a decentralized trial model because they found success reaching new patients during the pandemic, as patients opted to stay home or avoid massive health care centers as part of their social distancing efforts.

Other advantages of decentralized trials include:

  • Accelerated patient access
  • Improved patient engagement and retention
  • Increased diversity

Challenge: Communication and Exchange of Data

One of the challenges that sites faced as they moved to decentralized trials was the ability to communicate and share data. These teams used to operate alongside the central research operations teams, but now they were operating in alternate locations.

Where central research operations teams had unlimited access to on-premise data and the ease of connecting with someone in-house, they were forced to operate through delayed communication or shared spreadsheets.

The Answer: Devana Solutions

Devana Solutions provided these teams with customized cloud software that brings clinical research sites to patients in these underserved communities so they can benefit from clinical research as a care option.

Devana’s cloud technology also allows highly-skilled research operations professionals to share protocols and other supporting trial documentation with decentralized sites and community-based providers.

More importantly, Devana allows centralized researchers to collaborate with the sites during study start-up and through trial completion, regardless of the trial location.

The future of clinical research is bright. As the industry continues to evolve, Devana Solutions’ capabilities will evolve, as well.

Learn How to Achieve Better Data, Better Decisions, Better Outcomes

Devana Solutions is an innovative cloud software provider that supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana Solutions even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems.

Let us show you in more detail what Better Data, Better Decisions, Better Outcomes could do for your clinical trial processes.

Book a demo with Devana Solutions today to learn about our cloud-based data analytics software for the clinical trials industry that integrates seamlessly with CTMS and other key systems to keep success in the crosshairs.

Events | Partner Spotlight

Devana Solutions Joins Global Leader in Blood Cancer Fight

February 8, 2022 by

Devana Solutions is proud to announce their sponsorship of the Leukemia & Lymphoma Society's Students of the Year program and Grace and Jack Sherner’s Raise Hope Together team.Devana Solutions is proud to announce their sponsorship of Team Raise Hope Together, formed by Grace and Jack Sherner, as part of the Leukemia & Lymphoma Society Students of the Year program. Students of the Year is a philanthropic leadership development program for exemplary high school students that fosters professional skills such as entrepreneurship, marketing, and project management. The students involved in this campaign raise funds for The Leukemia & Lymphoma Society, the world’s largest nonprofit fighting blood cancer.

The Sherners, along with their friend Theo Weiman, formed Team Raise Hope Together in honor of their children’s grandfather, Larry Thayer, who was diagnosed with CLL (Chronic Lymphocytic Leukemia) in 2007.

In April of this past year, their children’s aunt, Betsy, found a tumor on her left breast. Days later, she received a breast cancer diagnosis. In the months since, she has undergone a double mastectomy and a complete hysterectomy.

Devana Solutions is joining to be a part of the generation that puts an end to cancer and provides a monumental impact in the fight.

Devana Solutions’ CEO and Co-founder Barry Lake comments on the effort, “We are proud to support Leukemia & Lymphoma Society and the Students of the Year program. We strive to offer solutions to those committed to the fight against cancer, helping those researchers on the frontline close the gap in eliminating cancer by cutting time and costs in the drug development process. One day, we will defeat cancer!”

The Leukemia & Lymphoma Society is on a mission to cure leukemia, lymphoma, Hodgkin’s disease and myeloma and improve the quality of life for patients and their families. Since 1949, the Leukemia & Lymphoma Society has invested more than $1.5 billion in research to advance therapies and save lives. Today, blood cancer patients live longer because of these advancements made possible by the Leukemia & Lymphoma Society.

The family remains committed to defeating their diagnoses. “I continue to work on my personal recovery, which requires piecing together a new body, mind, and spirit,” their Aunt Betty said.

Join Devana Solutions before March 12 with your donation to Team Raise Hope Together.

Analytics | PROPEL

Take Clinical Trial Management to the Next Level with LYNK

February 1, 2022 by

As a technology provider that connects central trial operations teams with decentralized site staff and clinicians, our goal at Devana Solutions is to help research organizations speed new therapies to patients by automating clinical trial processes and capturing site metrics for analysis and execution.

You may be familiar with PROPEL, our enterprise-level platform for managing an expansive research organization consisting of owned or affiliated investigative sites or study teams. By leveraging the cloud to connect central research operations professionals with site-based clinicians and staff for real-time, clinical trial collaboration, it provides easy access to all of the information on trials, sites, users, and contacts at your organizational level. Organizations such as Velocity Clinical Research use PROPEL to create cohesive operations and improve efficiency within their organization and accelerate study startup.

What you may not be familiar with, however, is LYNK—the site-facing extension of the PROPEL platform that expands the capabilities to key site-level staff. LYNK takes PROPEL one step further, giving sites even more ways to streamline processes and increase efficiency. LYNK is the sites’ personalized interface that allows them to receive and respond to trial opportunities and quickly and easily complete feasibility assessments.

Manage Clinical Trial Opportunities

The LYNK interface will automatically notify the sites when a new clinical trial opportunity is sent by the central team. The site LYNK user can review the specifics of each trial, determine which investigator is best for the project, and instantly provide information that is necessary to complete the feasibility assessment. LYNK’s investigator profiles store all vital documents for the sites’ investigators, such as medical licenses, CVs, and training certificates. With LYNK, sites won’t need to sift through emails, document folders, or physical files, because all of this necessary information is located in one place.

Simplify Feasibility Questionnaires

Thanks to LYNK, the cumbersome feasibility process is simplified. Available in the LYNK dashboard, sites can view any outstanding feasibility questionnaires, which will auto populate with the previously answered, common information that is also found in their site’s profile, including contact information, on-site equipment and staff, and specific areas of therapeutic experience. Because LYNK stores all of the necessary data in site profiles, sites won’t need to search for the information in documents and spreadsheets—it’s available instantly.

These are just a couple of ways LYNK works seamlessly in conjunction with PROPEL, providing benefits not only to the greater research organization but to the sites, as well. Book a demo with Devana Solutions today to discover what LYNK can do to take your sites’ clinical trial management to the next level.

1 2